Product image of Xospata (Gilteritinib) supplied by GNH India

Xospata

Active Ingredient:
Gilteritinib
Origin:
EU

Xospata (Gilteritinib)

Xospata (gilteritinib) is an oral medication used for acute myeloid leukemia (AML) treatment. It belongs to the FLT3 inhibitor class, targeting specific mutations in AML cells. This targeted therapy supports disease management in adult patients. A prescription is required for use.

Manufacturer / TM Owner

Astellas Pharma Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xospata (gilteritinib) is prescribed for adults with acute myeloid leukemia (AML), particularly those with a FLT3 mutation. It is used when AML has returned or does not respond to initial treatment. The medication works by blocking signals that help cancer cells grow. Patients may ask, 'what is gilteritinib used for' to understand its role in AML care.

Side Effects

  • Xospata (gilteritinib) is taken by mouth and may help control symptoms associated with AML, such as fatigue or infections. Some patients notice improved energy levels or reduced complications over time. Individual responses vary, and effects depend on the disease stage and overall health. Regular monitoring is important during treatment.

Precautions & Warnings

  • Xospata (gilteritinib) should be handled with care, especially by those with liver or kidney concerns. Patients must follow their healthcare provider’s instructions closely and report any unusual symptoms promptly. It is not recommended for use during pregnancy or breastfeeding without medical advice. Keep the medication in a safe, dry place away from children.

Avoid Interactions

  • Xospata (gilteritinib) may interact with certain medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness. Grapefruit products and St. John’s wort are examples of substances to avoid. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they use. Alcohol use may also need to be limited during treatment.

Frequently Asked Questions

Xospata (gilteritinib) is used to treat acute myeloid leukemia (AML) in adults, particularly those with a FLT3 mutation.

Xospata is an oral medication, typically taken once daily as directed by a healthcare provider.

Common side effects may include fatigue, nausea, or changes in liver function tests.

Xospata may interact with certain drugs; consult your doctor before combining it with other medications.

Xospata is not recommended during pregnancy or breastfeeding unless specifically advised by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Gilteritinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT